Last updated on June 2019

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

Brief description of study

The primary objective of this study is to obtain de-identified, clinically-characterized whole blood specimens for use in developing and evaluating the performance of new biomarker assays for detection of hepatocellular carcinoma (HCC).

Detailed Study Description

Subjects with untreated Hepatocellular Carcinoma (HCC) and subjects undergoing HCC surveillance will be enrolled and have blood samples collected. Subjects undergoing HCC surveillance will be followed for up to 6 months. Another blood sample will be collected at the 6 month visit which will be scheduled no longer than 6 months from enrollment.

Clinical Study Identifier: NCT03628651

Find a site near you

Start Over

Helios Klinikum Berlin-Buch

Berlin, Germany
  Connect »